Results 31 to 40 of about 5,407 (178)

Medication prescription patterns in cancer rehabilitation physiatry outpatients: A multicenter retrospective study

PM&R, EarlyView.
Abstract Background and Objective Previous work from this dataset found 45% prescribing frequency of any medications (35.1%, 33.5%, and 56.8% at institutions 1, 2, and 3 respectively), without significant difference between in‐person and telemedicine.
Matthew Chen, Nafis Eghrari, David Leong, Philip Chang, Jasmine Zheng, Amy Ng, Richard Wilson, Mary Vargo   +7 more
wiley   +1 more source

Habitual fasting duration and accelerated multimorbidity in older adults

Journal of Internal Medicine, EarlyView.
Abstract Background Prolonged fasting has been linked to metabolic benefits in younger adults, but its effects on chronic diseases in older populations remain unclear. Objective To examine the association between habitual fasting duration and 15‐year chronic disease accumulation in older adults, overall, within organ systems, and between age groups ...
Luis Kalmbach, David Abbad‐Gomez, Giorgi Beridze, Fernando Rodríguez‐Artalejo, Davide Liborio Vetrano, Amaia Calderón‐Larrañaga, Adrián Carballo‐Casla   +6 more
wiley   +1 more source

The role of antibiotics in preventing surgical complications in periodontology and implant dentistry

Periodontology 2000, EarlyView.
Abstract Antibiotics are commonly prescribed in periodontal and implant surgeries, either before, during or after surgery, to prevent postoperative infection and reduce early implant failure. However, the potential benefits may be undermined by the risks of resistance and sensitization, thus requiring a strict indication for prescription.
Zhaozhao Chen, Lan‐Lin Chiou, Javier Calatrava, Hom‐Lay Wang   +3 more
wiley   +1 more source

Insomnia Treatment Preferences and Barriers of Individuals With Arthritis

ACR Open Rheumatology, Volume 8, Issue 8, August 2026.
Objective Sleep disturbances, including difficulty initiating sleep, maintaining sleep or early morning awakenings, are prevalent in arthritis, contributing to fatigue, pain, and reducing quality of life. Cognitive‐behavioral therapy for insomnia (CBTi) is the first‐line treatment. Accessibility remains challenging.
Emilie McGuire, Nicole J. Andersen, Diane Lacaille, Josée Savard, Paul R. Fortin, Elham Rahme, Deborah Da Costa   +6 more
wiley   +1 more source

An Open‐Label, 2‐Period, Fixed Sequence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder), with and without Concomitant Itraconazole in Healthy Adult Subjects

The Journal of Clinical Pharmacology, Volume 66, Issue 8, August 2026.
Abstract Dihydroergotamine (DHE) prescribing information contains a boxed warning regarding the possibility of serious and/or life‐threatening peripheral ischemia with co‐administration of strong cytochrome P450 3A4 (CYP3A4) inhibitors. The effects of the strong CYP3A4 inhibitor itraconazole on the pharmacokinetics and safety of nasally administered ...
Detlef Albrecht, Elizabeth Hussey, Richard B. Lipton   +2 more
wiley   +1 more source

A Codesigned Approach to Develop Tailored Antimicrobial Stewardship Strategies in Bangladesh: A Social–Ecological Systems Framework Analysis

Health Expectations, Volume 29, Issue 4, August 2026.
ABSTRACT Background Multistakeholder collaboration and codesign are increasingly recognized as effective approaches for addressing complex public health challenges such as antimicrobial resistance (AMR), yet stewardship efforts in low‐ and middle‐income countries remain fragmented and are often limited to education‐focused interventions with minimal ...
Abdullah Al Masud, Kamal Ibne Amin Chowdhury, Ramesh Lahiru Walpola, S. M. Zafar Shafique, Tamanna Sultana, Maria Akter, Nisharggo Niloy, Md Saiful Islam, Holly Seale   +8 more
wiley   +1 more source

Utilization of Artificial Intelligence as Simulated Patients to Enhance Student Interviewing Skills in the Pharmacy Curriculum Across Multiple Programs

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 7, July 2026.
ABSTRACT Background Traditional methods to practice patient interviewing skills for student pharmacists include the use of actors and role‐playing. While effective, they can be difficult to manage with large class sizes, cost, and time to train. Artificial intelligence (AI) and large language models (LLMs) are readily accessible to offer students a ...
Joseph M. Walter, Lucio Volino, Laura Knockel, Erika L. Kleppinger, Jarod Parrish, Rachel Stafford   +5 more
wiley   +1 more source

Human Disposition, Metabolism, and Excretion of Sevasemten (EDG‐5506), a Selective Modulator of Fast Myosin in Healthy Volunteers

The Journal of Clinical Pharmacology, Volume 66, Issue 7, July 2026.
Abstract Sevasemten (EDG‐5506) is a novel, orally bioavailable, investigational small molecule designed to selectively modulate type II fast skeletal myosin with the goal of protecting dystrophic muscle from contraction‐induced injury. Sevasemten is in clinical development for the treatment of Becker and Duchenne muscular dystrophy.
Molly Madden, Marc Evanchik, Jonathan Lane, Joanne Donovan, Alan J. Russell, Jeffrey A. Silverman   +5 more
wiley   +1 more source

Barriers and Facilitators for Information Exchange during Over-The-Counter Consultations in Community Pharmacy: A Focus Group Study

Pharmacy, 2017
Consumers are confident managing minor ailments through self-care, often self-medicating from a range of over-the-counter (OTC) medicines available from community pharmacies.
Liza J Seubert, Kerry Whitelaw, Fabienne Boeni, Laetitia Hattingh, Margaret C Watson, Rhonda M Clifford   +5 more
doaj   +1 more source

A Multipart Phase 1 Study to Assess Safety and Pharmacokinetics of Ibuzatrelvir in Healthy Participants and Dose Selection for a Dose‐Ranging Study

Clinical and Translational Science, Volume 19, Issue 7, July 2026.
ABSTRACT COVID‐19 continues to be a threat to global health and a burden on healthcare systems. There is an ongoing need for COVID‐19 antiviral therapies that are safe and effective across broad patient populations. Ibuzatrelvir is a potent, selective inhibitor of the SARS‐CoV‐2 main protease and demonstrated favorable properties for clinical ...
Ravi Shankar P. Singh, Sima S. Toussi, Frances Hackman, Mona Shahbazi, John Prybylski, Siddhee A. Sahasrabudhe, Penelope Crownover, Eugene P. Kadar, Billy T. George, Negar Niki Alami, Arthur Bergman   +10 more
wiley   +1 more source